Cord Blood America Announces Purchase of Minority Interest in Spanish Stem Cell Storage Company
Cord Blood America, Inc. announced that it has purchased a minority interest in Stem Cells VIDAPLUS, a Spanish-owned company which preserves umbilical cord stem cells at the Institute of Transfusion Medicine and Immunology of the Red Cross in Frankfurt, Germany. [Cord Blood America, Inc. Press Release] A Total of $6.5 Million in New Financing for the Centre de cancérologie Charles-Bruneau
In its continued efforts to meet the priorities of the Centre de cancérologie Charles-Bruneau at CHU Sainte-Justine, the Fondation Centre de cancérologie Charles-Bruneau is proud to announce that it has pledged to remit $6,444,524 in new financing to the Centre de cancérologie Charles-Bruneau over the next five years. These funds will be earmarked primarily for the fundamental research program on neuroblastoma as well as the research program on cord blood. [CNW Group]
UMASS Medical School’s Human Stem Cell Bank Makes Available First Seven Stem Cell Lines
The first seven stem cell lines grown and banked at the University of Massachusetts (UMASS) Medical School’s Human Stem Cell Bank are ready for worldwide distribution to researchers working on discovering new therapeutic treatments for diseases such as cancer, juvenile diabetes, Alzheimer’s and Parkinson’s, among others. [EurekAlert!]
UCSF Stem Cell Building Opens, a Milestone for Pioneering Program
The University of California, San Francisco (UCSF) celebrates the official opening of the Ray and Dagmar Dolby Regeneration Medicine Building, a testament to the power of perseverance in the stem cell field. [University of California, San Francisco Press Release]
ERYtech Pharma Announces Appointment of Marc Beer to the Supervisory Board
ERYtech Pharma, an emerging specialty pharma company, is pleased to welcome Marc Beer as a new board member. [ERYtech Inc. Press Release]
BME Grad Student Team Scores in Business Plan Competition
A team of Johns Hopkins biomedical engineering (BME) graduate students tied for first place in the 2011 Georgia Bowl Business Plan Competition, hosted Feb. 4 and 5 by Kennesaw State University. Team members presented their business plan for TheraCord, a system that the students developed to improve the process of umbilical cord blood collection. [Johns Hopkins University Press Release]
Scientists Warn Against Stifling Effect of Widespread Patenting in Stem Cell Field
A team of scholars urges the scientific community to act collectively to stem the negative effects of patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law, and common practice, the experts insist. [Johns Hopkins Berman Institute of Bioethics Press Release]
Pace Picks Up for Clinical Trials to Evaluate Stem Cell Therapies
Stem cell science remains a fast-moving frontier — that much was made clear by leading scientists discussing their latest discoveries during a scientific symposium honoring the opening of the Ray and Dagmar Dolby Regeneration Medicine Building on the University of California, San Francisco Parnassus campus. [University of California, San Francisco Press Release]